Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000003

CHIEF SCIENTIFIC OFFICER acquired 43,368 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-03-19 Grant or award +43,368 228,960 D
Derivatives
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-03-19 Grant or award · Employee Stock Option (right to buy) +53,703 53,703 D
Loading xslF345X06/form4-03232026_040305.xml…